Skip to content

Investigating the neural correlates of repeated tDCS in MCI and healthy ageing with fMRI

Investigating the neural correlates of repeated tDCS in MCI and healthy ageing with fMRI - Neural correlates of repeated tDCS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43086
Enrollment
80
Registered
2017-02-15
Start date
2017-05-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Participants will receive either active tDCS or sham tDCS on five consecutive days. Participants and the experimenter will be blind to the stimulation condition. Participants are randomly assigned t

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients - Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic (prof. Frans RJ Verhey): presence of at least a memory impairment, memory complaints expressed by the patient or informant, no problems in daily life functioning, no dementia and presence of biomarkers (Albert et al., 2011) - Clinical Dementia Rating score of 0.5 (CDR distinguishes a stage of questionable dementia (CDR 0.5) from people termed healthy (CDR 0) and those with mild dementia (CDR 1) - Mini-Mental State Examination (MMSE) 23 and being mentally competent (in general, individuals with a MMSE 18 are considered mentally competent) - Age: between 60 and 85 years old - 50% female - Right-handedness - Average level of education (CBS level 3-4-5-6);Healthy controls - Average neuropsychological test results, in accordance with normative data, corrected for age, education and gender - No substantial memory complaints (according to the participant) - Age: between 60 and 85 years old - 50% female - Right-handedness - Average level of education (CBS level 3-4-5-6) - Normal or corrected to normal vision

Exclusion criteria

Exclusion criteria: - Psychoactive medication use - Abuse of alcohol and drugs - Cognitive impairment due to alcohol/drug abuse or abuse of other substances - Past or present psychiatric or neurological disorders (major depression, schizophrenia, bipolar disorder, psychotic disorder (or treatment for it), epilepsy, stroke, Parkinson*s disease, multiple sclerosis, brain surgery, brain trauma, electroshock therapy, kidney dialysis, Menière*s disease, brain infections) - Major vascular disorders (e.g. stroke) - Heart diseases or pacemakers - Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, body tattoos) - Large scars or fresh wounds on the scalp

Design outcomes

Primary

MeasureTime frame
The main outcome measures are the Blood Oxygenation Level Dependent (BOLD) reflecting brain activity during the functional task and functional connectivity changes reflecting network integrity.

Secondary

MeasureTime frame
Secondary study parameters are performance on a pattern separation episodic memory task (accuracy and reaction times). Performance on the task will be correlated with BOLD-signal per session.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)